Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis

被引:0
|
作者
Brian C. Ferslew
Guoxiang Xie
Curtis K. Johnston
Mingming Su
Paul W. Stewart
Wei Jia
Kim L. R. Brouwer
A. Sidney Barritt
机构
[1] University of North Carolina at Chapel Hill,Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy
[2] Theravance Biopharma US,Clinical Pharmacology and Drug Metabolism and Pharmacokinetics
[3] Inc.,Metabolomics Shared Resource
[4] University of Hawaii Cancer Center,Department of Biostatistics, UNC Gillings School of Global Public Health
[5] University of North Carolina at Chapel Hill,Division of Gastroenterology and Hepatology, UNC School of Medicine
[6] University of North Carolina at Chapel Hill,undefined
来源
关键词
Nonalcoholic steatohepatitis; Bile acids; Bile acid metabolome; Enterohepatic recirculation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3318 / 3328
页数:10
相关论文
共 50 条
  • [1] Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis
    Ferslew, Brian C.
    Xie, Guoxiang
    Johnston, Curtis K.
    Su, Mingming
    Stewart, Paul W.
    Jia, Wei
    Brouwer, Kim L. R.
    Barritt, A. Sidney
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (11) : 3318 - 3328
  • [2] Altered Morphine Glucuronide and Bile Acid Disposition in Patients With Nonalcoholic Steatohepatitis
    Ferslew, B. C.
    Johnston, C. K.
    Tsakalozou, E.
    Bridges, A. S.
    Paine, M. F.
    Jia, W.
    Stewart, P. W.
    Barritt, A. S.
    Brouwer, K. L. R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 (04) : 419 - 427
  • [3] Altered bile acid composition and disposition in a mouse model of nonalcoholic steatohepatitis
    Suga, Takahiro
    Yamaguchi, Hiroaki
    Ogura, Jiro
    Shoji, Saori
    Maekawa, Masamitsu
    Mano, Nariyasu
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2019, 379
  • [4] Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH)
    Fiorucci, Stefano
    Biagioli, Michele
    Sepe, Valentina
    Zampella, Angela
    Distrutti, Eleonora
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (06) : 623 - 632
  • [5] Bile acid and nonalcoholic steatohepatitis: Molecular insights and therapeutic targets
    Cheng, Zilu
    Chen, Yixiong
    Schnabl, Bernd
    Chu, Huikuan
    Yang, Ling
    [J]. JOURNAL OF ADVANCED RESEARCH, 2024, 59 : 173 - 187
  • [6] Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis
    Tanaka, Naoki
    Matsubara, Tsutomu
    Krausz, Kristopher W.
    Patterson, Andrew D.
    Gonzalez, Frank J.
    [J]. HEPATOLOGY, 2012, 56 (01) : 118 - 129
  • [7] EFFECTS OF INDIVIDUAL BILE ACID FEEDING ON NONALCOHOLIC STEATOHEPATITIS DEVELOPMENT IN LOW BILE ACID MOUSE MODEL
    Taylor, Rulaiha E.
    Meadows, Vik
    Capece, Gina
    Basaly, Veronia
    Henry, Zakiyah
    Otersen, Katherine D.
    Kong, Bo
    Guo, Grace L.
    [J]. HEPATOLOGY, 2023, 78 : S1087 - S1088
  • [8] Carvedilol impairs bile acid homeostasis in mice: implication for nonalcoholic steatohepatitis
    Lastuvkova, Hana
    Nova, Zuzana
    Hroch, Milos
    Faradonbeh, Fatemeh Alaei
    Schreiberova, Jolana
    Mokry, Jaroslav
    Faistova, Hana
    Stefela, Alzbeta
    Dusek, Jan
    Kucera, Otto
    Hyspler, Radomir
    Dohnalkova, Ester
    Bayer, Rachel L.
    Hirsova, Petra
    Pavek, Petr
    Micuda, Stanislav
    [J]. TOXICOLOGICAL SCIENCES, 2023, 196 (02) : 200 - 217
  • [9] Targeting hepatic ceruloplasmin mitigates nonalcoholic steatohepatitis by modulating bile acid metabolism
    Jiang, Quanxin
    Wang, Ning
    Lu, Sijia
    Xiong, Jie
    Yuan, Yanmei
    Liu, Junli
    Chen, Suzhen
    [J]. JOURNAL OF MOLECULAR CELL BIOLOGY, 2024, 15 (09)
  • [10] Kaempferol attenuates nonalcoholic steatohepatitis by regulating serum and liver bile acid metabolism
    Lu, Yifei
    Shao, Mingmei
    Zhang, Caiyun
    Xiang, Hongjiao
    Wang, Junmin
    Wu, Tao
    Ji, Guang
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13